Working…
ClinicalTrials.gov

Key Record Dates

ClinicalTrials.gov Identifier: NCT00928330
Brief Title: Trastuzumab and Trastuzumab-MCC-DM1 Administered Intravenously and GDC-0941 Administered Orally to Patients With HER2-Positive Metastatic Breast Cancer Who Have Progressed on Previous Trastuzumab-Based Therapy

First Submitted : June 23, 2009
First Submitted that Met QC Criteria : June 24, 2009
First Posted : June 25, 2009 (Estimate)

Last Update Submitted that Met QC Criteria : November 1, 2016
Last Update Posted : November 2, 2016 (Estimate)